Table 1.
BV/TV |
Tb.Th |
Tb.Sp |
Tb.N |
BSA |
||||||
---|---|---|---|---|---|---|---|---|---|---|
PBS | C4-2 | PBS | C4-2 | PBS | C4-2 | PBS | C4-2 | PBS | C4-2 | |
αvβ3 (—) (4) | -65.23±6.57 | -73.93±7.08 | -26.56±5.38 | -17.06±1.07 | 44.07±6.22 | 105.38±33.21 | -21.87±8.16 | -32.98±11.51 | -49.16±10.27 | -62.71±2.74 |
P1 | 0.37* | 0.27 | 0.25 | 0.19 | 0.49 | |||||
αvβ3 WT (4) | -70.62±2.04 | -60.07±9.12 | -20.11±3.82 | -10.77±7.82 | 76.18±25.90 | 52.29±20.56 | -33.03±4.67 | -22.22±4.22 | -56.44±2.35 | -57.27±7.05 |
P1 | 0.26 | 0.21 | 0.27 | 0.0008** | 0.92 | |||||
P2 | 0.16 | 0.99 | 0.049* | 0.0007** | 0.40 | |||||
αvβ3 inactive (4) | -52.21±16.03 | -37.42±4.59 | -26.11±1.34 | -8.48±5.39 | 65.52±31.37 | 43.83±18.99 | -21.94±9.95 | -18.56±4.69 | -21.79±28.65 | -10.61±15.37 |
P1 | 0.35 | 0.079 | 0.73 | 0.72 | 0.64 | |||||
P2 | 0.30 | 0.48 | 0.047* | 0.33 | 0.40 | |||||
αvβ3 CA (7) | -74.25±5.84 | -62.14±13.04 | -19.50±9.40 | -24.28±8.02 | 75.12±22.09 | 67.35±18.82 | -32.31±4.72 | -28.73±5.74 | -60.86±4.97 | -48.01±14.90 |
P1 | 0.19 | 0.45 | 0.26 | 0.37 | 0.35 | |||||
P2 | 0.23 | 0.68 | 0.16 | 0.086 | 0.34 |
Abbreviations: BSA, bone surface area; PBS, phosphate-buffered saline; BV/TV, % bone in tissue volume; Tb.N, trabecular number; Tb.Sp, trabecular spacing; Tb.Th, trabecular thickness. MicroCT analyses of bone indices were performed within a 1 mm VOI adjacent to the growth plate (number of animals per group are indicated in parenthesis next to groupings). Values for PBS and C4-2 injected tibiae are expressed as %change of index over time of injected tibiae for each animal group. All values are expressed as mean±s.e. Statistical significance was determined using Student’s t-test as follows. Values were determined by comparing the mean difference (C4-2-PBS control) in increase over time. P1=two-tailed t-test for paired samples (C4-2 vs PBS control, same group), P2=two-tailed t-test (C4-2 — PBS control) of αvβ3 (—) group vs the specified group (C4-2 — PBS control)
P<0.05
P<0.01